thymine has been researched along with Hyperlipidemias in 2 studies
Hyperlipidemias: Conditions with excess LIPIDS in the blood.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In the postprandial lipemia after a fat load, the 56G carriers showed a significant decrease in the area under curve for TG and increase for HDL-C than the noncarriers." | 2.73 | Fenofibrate effect on triglyceride and postprandial response of apolipoprotein A5 variants: the GOLDN study. ( Adiconis, X; Arnett, DK; Corella, D; Hixson, JE; Lai, CQ; Ordovas, JM; Parnell, LD; Peacock, JM; Province, MA; Straka, RJ; Tsai, MY, 2007) |
| "Combined hyperlipidemia (CHL) is a very frequent dyslipidemia, being lipid-lowering drugs often necessary in its management." | 2.71 | Genetic variation in the hepatic lipase gene is associated with combined hyperlipidemia, plasma lipid concentrations, and lipid-lowering drug response. ( Arístegui, R; Artieda, M; Cenarro, A; Civeira, F; Díaz, C; Gañán, A; Gonzalvo, C; Meriño-Ibarra, E; Pocoví, M; Sol, JM, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cenarro, A | 1 |
| Artieda, M | 1 |
| Gonzalvo, C | 1 |
| Meriño-Ibarra, E | 1 |
| Arístegui, R | 1 |
| Gañán, A | 1 |
| Díaz, C | 1 |
| Sol, JM | 1 |
| Pocoví, M | 1 |
| Civeira, F | 1 |
| Lai, CQ | 1 |
| Arnett, DK | 1 |
| Corella, D | 1 |
| Straka, RJ | 1 |
| Tsai, MY | 1 |
| Peacock, JM | 1 |
| Adiconis, X | 1 |
| Parnell, LD | 1 |
| Hixson, JE | 1 |
| Province, MA | 1 |
| Ordovas, JM | 1 |
2 trials available for thymine and Hyperlipidemias
| Article | Year |
|---|---|
Genetic variation in the hepatic lipase gene is associated with combined hyperlipidemia, plasma lipid concentrations, and lipid-lowering drug response.
Topics: Adult; Aged; Atorvastatin; Bezafibrate; Cytosine; Female; Genetic Variation; Genotype; Heptanoic Aci | 2005 |
Fenofibrate effect on triglyceride and postprandial response of apolipoprotein A5 variants: the GOLDN study.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Apolipoprotein A-V; Apolipoprotein | 2007 |